Furthermore, rodent studies showed that IL-33 had a therapeutic effect in a mouse model of Alzheimer disease, attenuating cellular pathologies and recovering behavioral phenotypes (Fu et al., 2016). Here, IL33 is linked to early-onset autosomal dominant Alzheimer disease.